Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Shares Issued (2016 - 2025)

Avanos Medical's Shares Issued history spans 10 years, with the latest figure at $600000.0 for Q3 2024.

  • For Q3 2024, Shares Issued fell 33.33% year-over-year to $600000.0; the TTM value through Dec 2024 reached $1.1 million, down 15.38%, while the annual FY2025 figure was $700000.0, 36.36% down from the prior year.
  • Shares Issued for Q3 2024 was $600000.0 at Avanos Medical, up from $500000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.8 million in Q1 2021 and bottomed at -$200000.0 in Q4 2023.
  • The 5-year median for Shares Issued is $600000.0 (2020), against an average of $828571.4.
  • The largest annual shift saw Shares Issued rose 12.5% in 2021 before it crashed 300.0% in 2023.
  • A 5-year view of Shares Issued shows it stood at $800000.0 in 2020, then grew by 12.5% to $900000.0 in 2021, then plummeted by 88.89% to $100000.0 in 2022, then plummeted by 300.0% to -$200000.0 in 2023, then surged by 400.0% to $600000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Shares Issued are $600000.0 (Q3 2024), $500000.0 (Q1 2024), and -$200000.0 (Q4 2023).